Title: Breast and Ovarian Cancer
Purpose Statement: This speech has a primary goal of educating the audience and to give a better understanding of what breast cancer is and how it can be treated with detection by a vast variety of methods. It will also give better understanding that not only women but men also are susceptible to breast cancer.
Introduction
I. Attention: There are a number of researches done about breast and ovarian cancer. Breast cancer is the second largest cause of death in women. Ovarian cancer is the fourth largest cause of death in women, but there isn’t a lot of attention brought to the public by the media. There needs to be more awareness about these types of cancers for better education. II. Relevance: Everyone will be affected by cancer sometime in their life either directly or indirectly. Getting people the knowledge and information might help save a life. III. Thesis: Being tested and self-exams are the most proactive ways to catch it early to prevent death. IV. Preview: I will tell you the causes of breast and ovarian cancer. I will also tell you information about genetic testing.
[Transition: Let me first tell you what cancer is.]
Body
I. What is cancer? What is breast and ovarian cancer? A. Cancer is a cell that because immortal due to the loss of signal to die as the immortal cell continues to grow it splits its self and continues to duplicate this process until a mass is formed large enough to be felt or see in a scan. 1. Breast cancer an immortal cell that is located in the breast tissue, not only in women but men also. 2. Ovarian cancer is an immortal cell located in the ovarian tissue and the fallopian tubes. B. Approximately 2 million women in the United States have been diagnosed and treated for breast cancer and there was a reported 40,000 that lost their lives due to breast cancer in 2009 alone according to the Journal of Cell & Tissue Research.
References: Dite, G., Whittemore, A., Knight, J., John, E., Milne, R., Andrulis, I., & ... Hopper, J. (2010). Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. British Journal Of Cancer, 103(7), 1103-1108. doi:10.1038/sj.bjc.6605876. Retrieved February 22, 2012 from academic search complete Field, K. M., & de Boer, R. H. (2009). Male breast cancer: A review. Asia Pacific Journal Of Oncology & Hematology, 1(1), 19-26. Retrieved February 22, 2012 from academic search complete Finch, A. A., Metcalfe, K. K., Lui, J. J., Springate, C. C., Demsky, R. R., Armel, S. S., & ... Narod, S. S. (2009). Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clinical Genetics, 75(3), 220-224. doi:10.1111/j.1399-0004.2008.01117.x. Retrieved February 22, 2012 from academic search complete Manoharan, S. S., & Pugalendhi, P. P. (2010). Breast cancer: An overview. Journal Of Cell & Tissue Research, 10(3), 2423-2432. Retrieved February 22, 2012 from academic search complete Martin, V. R. (2007). Ovarian cancer: An overview of treatment options. Clinical Journal Of Oncology Nursing, 11(2), 201-207. doi:10.1188/07.CJON.201-207. Retrieved February 22, 2012 from academic search complete